Lixisenatide protects the neurovascular unit in diabetic retinopathy

被引：0
|
作者：
Acunman, K. [1 ]
Kolibabka, M. [1 ]
Dietrich, N. [1 ]
Schlotterer, A. [1 ]
Fleming, T. [2 ]
Wohlfart, P. [3 ]
Hammes, H. -P. [1 ]
机构：
[1] Univ Med Mannheim, Mannheim, Germany
[2] Univ Klinikum Heidelberg, Heidelberg, Germany
[3] Sanofi Aventis Deutschland GmbH, Frankfurt, Germany
来源：
DIABETOLOGIA | 2017年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1045
引用
收藏
页码：S481 / S482
页数：2
相关论文
共 50 条
  • [21] Peripapillary Neurovascular Coupling is Compromised in Early Diabetic Retinopathy
    Marques, Joao Pedro
    Rodrigues, Tiago Martins
    Teles, Joao Alves
    Soares, Mario
    Simao, Silvia
    Dolan, Michael-John
    Murta, Joaquim N.
    Silva, Rufino Martins
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [22] PERIPAPILLARY NEUROVASCULAR COUPLING IN THE EARLY STAGES OF DIABETIC RETINOPATHY
    Rodrigues, Tiago M.
    Marques, Joao P.
    Soares, Mario
    Dolan, Michael-John
    Melo, Pedro
    Simao, Silvia
    Teles, Joao
    Figueira, Joao
    Murta, Joaquim N.
    Silva, Rufino
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2019, 39 (12): : 2292 - 2302
  • [23] Neurovascular Cell Death and Therapeutic Strategies for Diabetic Retinopathy
    Oshitari, Toshiyuki
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (16)
  • [24] LncRNAS-modulators of neurovascular units in diabetic retinopathy
    Pu, Shengdan
    Xu, Yuxin
    Li, Xin
    Yu, Ziwei
    Zhang, Yitong
    Tong, Xuewei
    Shan, Yongyan
    Gao, Xinyuan
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2022, 925
  • [25] The effect of GLP-1 receptor agonist lixisenatide on experimental diabetic retinopathy
    Oezer, Kuebra
    Kolibabka, Matthias
    Gassenhuber, Johann
    Dietrich, Nadine
    Fleming, Thomas
    Schlotterer, Andrea
    Morcos, Michael
    Wohlfart, Paulus
    Hammes, Hans-Peter
    ACTA DIABETOLOGICA, 2023, 60 (11) : 1551 - 1565
  • [26] The effect of GLP-1 receptor agonist lixisenatide on experimental diabetic retinopathy
    Kuebra Oezer
    Matthias Kolibabka
    Johann Gassenhuber
    Nadine Dietrich
    Thomas Fleming
    Andrea Schlotterer
    Michael Morcos
    Paulus Wohlfart
    Hans-Peter Hammes
    Acta Diabetologica, 2023, 60 : 1551 - 1565
  • [27] Dapagliflozin treatment protects from diabetic retinopathy
    Bhatwadekar, Ashay D.
    Mathew, Deepa
    Dhami, Hurshdeep
    Bello, Erika
    Luo, Qianyi
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
  • [28] Diabetic retinopathy: neurovascular disease requiring neuroprotective and regenerative therapies
    Oshitari, Toshiyuki
    NEURAL REGENERATION RESEARCH, 2022, 17 (04) : 795 - 796
  • [29] Diabetic retinopathy: neurovascular disease requiring neuroprotective and regenerative therapies
    Toshiyuki Oshitari
    NeuralRegenerationResearch, 2022, 17 (04) : 795 - 796
  • [30] miRNAs, piRNAs, and lncRNAs: A triad of non-coding RNAs regulating the neurovascular unit in diabetic retinopathy and their therapeutic potentials
    Karpagavalli, Muthuramalingam
    Sindal, Manavi D.
    Arunachalam, Jayamuruga Pandian
    Chidambaram, Subbulakshmi
    EXPERIMENTAL EYE RESEARCH, 2025, 251
12345